A randomized, double blind study to investigate the therapeutic benefit of inhibiting the IL-5 receptor using benralizumab to treat severe rhinosinusitis with nasal polyps
Latest Information Update: 16 Feb 2022
At a glance
- Drugs Benralizumab (Primary)
- Indications Nasal polyps
- Focus Therapeutic Use
Most Recent Events
- 16 Feb 2022 New trial record